Prognostic importance of transferrin receptor expression and correlation with K1-67 labelling indices in intracranial meningiomas

References

• Jaaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma; late recurrence rate and factors, predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986;26:461 —9.
   Google Scholar
• May PL, Broome JC, Lawry J, Buxton R, Battersby RDE. The prediction of recurrence in meningiomas; a flow cytometric study of paraffin-embedded archival material. 3 Neurosurg 1989;71: 347–51.
   Google Scholar
• Abramovich CM, Prayson RA. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol 1998;29:1420–7.
   PubMed Web of Science ®Google Scholar
• Amatya VJ, Takeshima Y, Sugiyarna K, Kurisu K, Nishisaka T, Fukuhara T, Inai K. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1 and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum Pathol 2001;32: 970–5.
   Google Scholar
• Kakinuma K, Tanaka R, Onda K, Takahashi H. Proliferative potential of recurrent meningiomas as evaluated by labeling indices of BudR and Ki-67, tumour doubling time. Acta Neurochir (Wien) 1998;140:26–32.
   Google Scholar
• Karampitopoulou E, Perentes E, Tolnay M, Probst A. Prognostic significance of MIB-1, p53 and bc1-2 immuno-reactivity in meningiomas. Hum Pathol 1998;29:140–5.
   Google Scholar
• Kyung GC, Takao H, Tadashi N, Murovic JA, Wilson CB. Prediction of tumor doubling time in recurrent meningiomas. Neurosurg 1986;65:790–4.
   Google Scholar
• Langford LA, Cooksley CS, DeMonte F. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 1996;27: 350–4.
   Google Scholar
• Aisen P. Entry of iron into cells: a new role for the transferrin receptor in modulating iron release from transferrin. Ann Neurol 1992;32:62— 8.
   Google Scholar
• Connor JR, Brian SS, Paolo A, David AL, Peter LW. A quantitative analysis of isoferritins in selected regions of aged Parkinsonian and Alzheimer's diseased brains. 3 Neurochem 1995;65: 717–24.
   Google Scholar
• Huwyler J, Froidevaux S, Roux F, Eberle AN. Characteriza-tion of transferrin receptor in an immortalized cell line of rat brain endothelial cells, RBE4. 3 Recept Signal Transduct Res 1999;19: 729–39.
   Google Scholar
• Loeffler DA, Connor JR, Juneau PL, Snyder S, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA. Transferrin and iron in normal, Alzheimer's disease and Parkinson's disease brain regions. 3 Neurochem 1995;65: 710–16.
   Google Scholar
• Perl DP, Good PF. Comparative techniques for determining cellular iron distribution in brain tissues. Ann Neurol 1992;32:76— 81.
   Google Scholar
• Roelcke U, Leenders KL, von Ammon K, Radu EW, Vontobel P, Gunther I, Psylla M. Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate. Neurooncol 1996;29: 157— 65.
   Google Scholar
• Connor JR, Fine RE. Development of transferrin positive oligodendrocytes in the rat central nervous system. 3 Neurosci Res 1987;17:51–9.
   PubMed Web of Science ®Google Scholar
• Hill JM, Ruff MR, Weber RJ, Pert CB. Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Neurobiology 1985;82:4553–7.
   Google Scholar
• Hulet SW, Hess EJ, Debinski W, Arosio P, Bruce K, Powers S, Connor JR. Characterization and distribution of ferritin binding sites in the adult mouse brain. 3 Neurochem 1999;72: 868–74.
   Google Scholar
• Pardridge WM, Eisenberg J, Yang J. Human blood-brain barrier transferrin receptor. Metabolism 1987;36:892–5.
   Google Scholar
• Hall WA, Merrill MJ, Walbridge S, Youle RJ. Epidermal growth factor receptors on ependymomas and other brain tumors. JNeurosurg 1990;72:641 — 6.
   Google Scholar
• Colombatti M, Massimo B, Lorena DA, Massimo AG, Guiseppe T. Sensitivity of human glioma cells to cytotoxic heteroconjugates. Int 3 Cancer 1988;42: 441 —8.
   Google Scholar
• Gatter KC, Brown G, Strowbridge I, Woolston RE, Mason DY. Transferrin receptors in human tissues; their distribution and possible clinical relevance. 3 Gun Pathol 1983;36: 539— 45.
   Google Scholar
• Recht L, Torres CO, Smith TW, Raso V, Griffin TW. Transferrin receptor in normal and neoplastic brain tissue; implications for brain tumor immunotherapy. 3 Neurosurg 199072:941–5.
   Google Scholar
• Faulk PW, Bai LH, Stevens PJ. Transferrin and transferrin receptors in carcinoma of the breast. Lancet 1980;23:390–2.
   Google Scholar
• Feelders RA, Vreugdenhil G, Eggermont AM, Kuiper-Kramer PA, Van Eijk HG, Swaak AJ. Regulation of iron metabolism in the acute phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and decrease in circulating transferrin receptors in cancer patients. Eur I Clin Invest 1998;28:52–7.
   Google Scholar
• Tampanaru SA, Stefaneanu L, Thapar K, Kontogeorgos G, Sumi T, Kovacs K. Transferrin and transferrin receptor in human hypophysis and pituitary adenomas. Am I Pathol 1998;152:413–22.
   Google Scholar
• Simpson D. The recurrence of intracranial meningiomas after surgical treatment. I Neurol Neurosurg Psychiatry 1957;20:22 — 39.
   Google Scholar
• Hall WA, Godal A, Juell S, Fodstad 0. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme. Neurosurg 1992;76:838–44.
   Google Scholar
• Prior R, Reifenberger G, Wechsler W. Transferrin receptor expression in tumours of the human nervous system: relation to tumour type grading and tumour growth fraction. Virchows Arch A Pathol Anat Histopathol 1990;416:491–6.
   Google Scholar
• Wen DY, Hall WA, Conrad J, Godal A, Florenes VA, Fodstad 0. In vitro and in vivo variation in transferrin receptor expression on human medulloblastoma cell line. Neurosurgery 1995;36:1158–63.
   Google Scholar
• Hall WA. Transferrin receptor on glioblastoma multiforme (Letter). 3 Neurosurg 1991;74:313 —14.
   Google Scholar
• Sasaki K, Matsumura K, Tsuji T, Shinozzaki F, Takahashi M. Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors. Cancer 1988;62: 989–93.
   Google Scholar
• Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J. Meningioma proliferating potential and clinicoradiological features. Neurosurgery 1995;37:1049 —55.
   Google Scholar
• Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J. Preoperative identification of meningiomas that are highly likely to recur. I Neurosurg 1999;90:455–62.
   Google Scholar
• Nakasu S, Nakasu Y, Matsuda M. Meningioma recurrence. (Letter) 3 Neurosurg 2000;92: 897 — 98.
   Google Scholar
• Hall WA. Targeted toxin therapy for malignant astrocytoma. Neurosurgery 2000;46:544 —52.
   Google Scholar
• Johnson VG, Wrobel C, Wilson D, Zovickian J, Greenfield L, Oldfield EH, Youle R. Improved tumor specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia. I Neurosurg 1989;70:240–8.
   Google Scholar
• Laske DW, Youle RJ, Oldfield EH. Tumor regression with regional distribution of the targeted toxin TF-CRM 107 in patients with malignant brain tumors. Nat Med 1997;3: 1362 — 8.
   Google Scholar
• Martell LA, Agrawal A, Ross DA, Muraszko KM. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res 1993;15:1348–53.
   Google Scholar
• Singh M. Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 1999;1:443 — 51.
   Google Scholar
• Zovickian J, Johnson VG, Youle RJ. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody ricin immunotoxin. 3 Neurosurg 1987;66: 850–86.
   Google Scholar
• Bello L, Jianping Z, Demetrios CN, Jon FS, Roberto MV, David AC, Rona SC, Peter MB. avfi3 and avi35 integrin expression in meningiomas. Neurosurgery 2000;47:1185— 95.
   Google Scholar
• Lee CS, Redshaw A, Boag G. NM 23-H1 protein immuno-reactivity in laryngeal carcinoma. Cancer 1996;77: 2246–50.
   Google Scholar
• Nagashima G, Aoyagi M, Wakimoto H, Tamaki M, Ohno K, Hirakawa K. Immunohistochemical detection of progesterone receptors and correlation with Ki-67 labeling indices in paraffin embedded sections of meningiomas. Neurosurgery 1995;37:478— 82.
   Google Scholar
• Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M. Significance of MIB-1 staining indices in meningiomas; comparison of two counting methods. Am I Surg Pathol 2001;25: 472–8.
   Google Scholar
• Takashi T, Yasuhiro 0, Kengo M, Takashi 0. Peritumoral brain edema in intracranial meningiomas: effects of radiologi-cal and histological factors. Neurosurgery 2001;49: 1046 — 52.
   Google Scholar